The clinical observation of the treatment of prostatitis with Stasis Solid Fine Mixture showed no significant effect on liver function, renal function, or ECG, and no side effects were found. Thus, the Stasis Solid Fine Mixture as a new drug has better therapeutic effects for chronic prostatitis and is worth promoting. One typical case involved a 28-year-old married man, Hui, with case number 18. Chief Complaint: frequent urination accompanied by whitish discharge repeated over three years, worsened in the past week, diagnosed in the hospital urology department through digital rectal examination and prostate tests. He had taken Norfloxacin one week ago, showing improvement in symptoms such as frequent urination, pain, white turbidity, and tenderness. Digital rectal examination revealed prostate enlargement, microscopic examination of prostatic fluid showed white blood cells of 20-30 per high power field, lecithin +, hematuria (-), normal electrocardiogram, normal liver function, and normal renal function. Red tongue, yellow greasy coating, pulse slippery. Diagnosed with chronic prostatitis, Qi and Blood Stasis Heat Accumulation Type. Assigned to the treatment group, given nine bottles of Stasis Solid Fine Mixture, each serving 10g, three times a day for a total of four weeks. Symptoms disappeared, normal digital rectal examination of the prostate, prostatic fluid check WBC2-5/HP, egg lecithin +++ judged healed.
Another case involved a 41-year-old married Han male, case number 35. Chief Complaint: frequent urination, pain, gonorrhea for over three years plus five days, diagnosed at the Corps Hospital as prostatitis associated with hypertrophy. Digital rectal examination showed full light tenderness of the prostate, B-ultrasound revealed enlarged prostate capsule, prostatic fluid full vision of white blood cells, more than ++++. After four weeks of treatment with Stasis Solid Mixture, symptoms improved, normal B-ultrasound rectal check of the prostate, no tenderness; prostatic fluid white blood cells 20-22/HP, egg embroidery body still ++, judged effective.
A report from Xinjiang People's Hospital in Urumqi (83oooo) by Ma Jin, Wang Wei Hong, and Li Qi from the New Urban Epidemic Prevention Station in Urumqi (830o11) discussed 12 cases of acute leukemia and skin infiltration. Acute leukemia (AL) extramedullary infiltration of the skin-specific damage is not uncommon. Between 1991 and 2001, 12 cases of AL skin damage were diagnosed, accounting for 3.7% of the confirmed AL during the same period. The misdiagnosis rate was as high as 80%. This report summarizes the following: Clinical data of eight cases in this article reported a skin-specific damage of 12 patients with AL, 8 males and 4 females, aged from 13 to 71 years, mean age 46 years. Nine cases of acute non-lymphocytic leukemia (ANLL), including two cases of M2, one case of M4 type, six cases of Ms type. Three cases of acute lymphoblastic leukemia (ALL), one case of Ll-type, two cases. The first symptom at all levels of hospitals was misdiagnosed as various skin changes. After chemotherapy or bone marrow transplantation, complete remission or partial remission occurred in eight cases, and skin lesions recurred in four cases. Diagnosis was made by specialists using cytology and skin biopsy.
The site of skin damage: four cases of lower limbs, two cases of upper limbs, one case affecting all four limbs, three cases of trunk, multiple sites in two cases. Lesions varied from a few points to more than ten. Skin lesions: diameter 0.5-8.0 cm, hard nodules with pain or slight pain, unclear edges, color red, crimson, purple, varying in time and color. Center uplifted, darker border area lighter. Three cases of patients with lesional skin blistering, ulceration, oozing, and crusting. Original disease achieved remission through chemotherapy, reduction of leukemia cells in bone marrow and peripheral blood, and lesion areas reduced, color lighter, ulcers healed until they disappeared.
Discussion: AL skin infiltration can occur in various types of leukemia, especially in the acute phase or relapse, spreading to all parts of the body's skin. Starting many skin diseases treatment, especially in primary health care units or blood specialist sections of hospitals, is prone to misdiagnosis. Misdiagnosis leads to other skin therapy and leukemia clinical manifestations being considered too late after the possibility of AL skin infiltration, mostly in the late stage of leukemia. Correct diagnosis and treatment are needed to achieve complete remission. Leukemia patients should always consider the possibility of skin infiltration. Body skin examination should be one of the must-check contents. Leukemic skin infiltration is more common in monocytic leukemia in AL. In this article, six cases (50%) were M5. Skin, painless or slightly painful hard nodules, different colors, or ulceration oozing scab without other skin lame explanation requires further tests and experiments to diagnose early whether AL skin infiltration caused it. Hematologists and dermatologists should be alert to the misdiagnosis of AL lesions. Report of 12 cases of AL lesions, AL skin infiltrating lesions in the entire AL pathogenesis at any time may have chemotherapy to achieve remission patients may also have skin infiltration. And relapse or disease progression is the most powerful evidence. Although ill and chemotherapy and immunotherapy did not reach complete remission, more than died within six months. Therefore, AL skin infiltration should attract the attention of clinicians.